These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

393 related articles for article (PubMed ID: 7507795)

  • 1. Identification of occult micrometastases in pericolic lymph nodes of Duke's B colorectal cancer patients using monoclonal antibodies against cytokeratin and CC49. Correlation with long-term survival.
    Greenson JK; Isenhart CE; Rice R; Mojzisik C; Houchens D; Martin EW
    Cancer; 1994 Feb; 73(3):563-9. PubMed ID: 7507795
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Detection of lymph nodes micrometastases in Dukes' A and B colorectal cancer using anti-cytokeratin antibodies AE1/AE3.
    Zhou ZW; Rieger N; Ruszkiewicz A; Wang GQ; Wan DS
    World J Gastroenterol; 2005 Jun; 11(23):3640-3. PubMed ID: 15962393
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of influence of cytokeratin-positive mini micrometastases in "Negative Node" patients with colorectal cancer: findings from the national surgical adjuvant breast and bowel projects protocols R-01 and C-01.
    Fisher ER; Colangelo L; Wieand S; Fisher B; Wolmark N
    Dis Colon Rectum; 2003 Aug; 46(8):1021-5; discussion 1025-6. PubMed ID: 12907892
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Occurrence and prognostic importance of micrometastases in regional lymph nodes in Dukes' B colorectal carcinoma: an immunohistochemical study.
    Adell G; Boeryd B; Frånlund B; Sjödahl R; Håkansson L
    Eur J Surg; 1996 Aug; 162(8):637-42. PubMed ID: 8891622
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Incidence and prognostic implications of isolated tumor cells in lymph nodes from patients with Dukes B colorectal carcinoma.
    Choi HJ; Choi YY; Hong SH
    Dis Colon Rectum; 2002 Jun; 45(6):750-5; discussion755-6. PubMed ID: 12072625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prognostic significance of immunohistochemically detected lymph node micrometastases in colorectal carcinoma.
    Jeffers MD; O'Dowd GM; Mulcahy H; Stagg M; O'Donoghue DP; Toner M
    J Pathol; 1994 Feb; 172(2):183-7. PubMed ID: 7513353
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical significance of occult micrometastasis lymph nodes from patients with early gastric cancer who died of recurrence.
    Maehara Y; Oshiro T; Endo K; Baba H; Oda S; Ichiyoshi Y; Kohnoe S; Sugimachi K
    Surgery; 1996 Apr; 119(4):397-402. PubMed ID: 8644003
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intraoperative detection of occult colon cancer micrometastases using 125 I-radiolabled monoclonal antibody CC49.
    Cote RJ; Houchens DP; Hitchcock CL; Saad AD; Nines RG; Greenson JK; Schneebaum S; Arnold MW; Martin EW
    Cancer; 1996 Feb; 77(4):613-20. PubMed ID: 8616751
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The detection of cytokeratins in lymph nodes of Duke's B colorectal cancer subjects predicts a poor outcome.
    Clarke G; Ryan E; O'Keane JC; Crowe J; MacMathuna P
    Eur J Gastroenterol Hepatol; 2000 May; 12(5):549-52. PubMed ID: 10833099
    [TBL] [Abstract][Full Text] [Related]  

  • 10. For patients with Dukes' B (TNM Stage II) colorectal carcinoma, examination of six or fewer lymph nodes is related to poor prognosis.
    Caplin S; Cerottini JP; Bosman FT; Constanda MT; Givel JC
    Cancer; 1998 Aug; 83(4):666-72. PubMed ID: 9708929
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with curatively resected Dukes' B colorectal cancer.
    Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
    Oncol Rep; 2003; 10(5):1177-81. PubMed ID: 12883677
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How many lymph nodes should be examined in Dukes' B colorectal cancer? Determination on the basis of cumulative survival rate.
    Yoshimatsu K; Ishibashi K; Umehara A; Yokomizo H; Yoshida K; Fujimoto T; Watanabe K; Ogawa K
    Hepatogastroenterology; 2005; 52(66):1703-6. PubMed ID: 16334761
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Correlation between occult neoplastic cells in the lymph node sinuses and recurrence in patients with Dukes' C colorectal cancer.
    Mukai M; Sato S; Komatsu N; Nishida T; Shiba K; Ito I; Nakasaki H; Makuuchi H
    Oncol Rep; 2003; 10(5):1165-9. PubMed ID: 12883675
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic significance of perirectal lymph node micrometastases in Dukes' B rectal carcinoma: an immunohistochemical study by CAM5.2.
    Isaka N; Nozue M; Doy M; Fukao K
    Clin Cancer Res; 1999 Aug; 5(8):2065-8. PubMed ID: 10473087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Improvement of 10-year survival by Japanese radical lymph node dissection in patients with Dukes' B and C colorectal cancer: a 17-year retrospective study.
    Mukai M; Ito I; Mukoyama S; Tajima T; Saito Y; Nakasaki H; Sato S; Makuuchi H
    Oncol Rep; 2003; 10(4):927-34. PubMed ID: 12792747
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical significance of lymph node micrometastasis in stage I and stage II colorectal cancer.
    Davies M; Arumugam PJ; Shah VI; Watkins A; Roger Morgan A; Carr ND; Beynon J
    Clin Transl Oncol; 2008 Mar; 10(3):175-9. PubMed ID: 18321821
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Detection of occult metastases in lymph nodes from patients with colorectal carcinoma by reverse transcriptase-polymerase chain reaction.
    Liu Z; Ye X; Bi W; Wang M; Li Y; Chen T
    Chin Med J (Engl); 2002 Apr; 115(4):529-31. PubMed ID: 12133290
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of occult micrometastases in patients with early gastric cancer using anti-cytokeratin monoclonal antibodies.
    Saragoni L; Gaudio M; Morgagni P; Folli S; Bazzocchi F; Scarpi E; Saragoni A
    Oncol Rep; 2000; 7(3):535-9. PubMed ID: 10767364
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lymph node micrometastasis and survival of patients with Stage I (Dukes' A) colorectal carcinoma.
    Reggiani Bonetti L; Di Gregorio C; De Gaetani C; Pezzi A; Barresi G; Barresi V; Roncucci L; Ponz de Leon M
    Scand J Gastroenterol; 2011 Jul; 46(7-8):881-6. PubMed ID: 21492052
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The importance of combining xylene clearance and immunohistochemistry in the accurate staging of colorectal carcinoma.
    Haboubi NY; Clark P; Kaftan SM; Schofield PF
    J R Soc Med; 1992 Jul; 85(7):386-8. PubMed ID: 1378498
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.